A Dose of Compromise

Life was changing for the pharmaceutical industry even before the attacks on America. It had been a year of public relations embarrassments, including a lawsuit filed by 39 drug companies against South Africa over patent infringement legislation approved in a country where at least 4.7 million people are HIV positive. The suit was later withdrawn, but critics said the industry offered no social, political or ethical leadership in a global marketplace.

Then came Sept. 11. After the hijack terror followed bioterror — anthrax. Faced with the potential of a widespread public health emergency, U.S. officials scrambled to...

Want the full story?

Subscribe Now


Get TIME the way you want it

  • One Week Digital Pass — $4.99
  • Monthly Pay-As-You-Go DIGITAL ACCESS$2.99
  • One Year ALL ACCESSJust $30!   Best Deal!
    Print Magazine + Digital Edition + Subscriber-only Content on TIME.com

Learn more about the benefits of being a TIME subscriber

If you are already a subscriber sign up — registration is free!